Blood Research

Cited by CrossRef (9)

  1. Yaping Chang, Gordon H. Guyatt, Trevor Teich, Jamie L. Dawdy, Shaneela Shahid, Jessica K. Altman, Richard M. Stone, Mikkael A. Sekeres, Sudipto Mukherjee, Thomas W. LeBlanc, Gregory A. Abel, Christopher S. Hourigan, Mark R. Litzow, Laura C. Michaelis, Shabbir M. H. Alibhai, Pinkal Desai, Rena Buckstein, Janet MacEachern, Romina Brignardello-Petersen, Francesco Bertolini. Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review. PLoS ONE 2021;16:e0249087
    https://doi.org/10.1371/journal.pone.0249087
  2. Hyerim Ha, Yujin Jeong, Joo Han Lim, Young Ju Suh. Treatment Pattern, Financial Burden, and Outcomes in Elderly Patients with Acute Myeloid Leukemia in Korea: A Nationwide Cohort Study. IJERPH 2022;19:2317
    https://doi.org/10.3390/ijerph19042317
  3. Yong Won Choi, Seong Hyun Jeong, Mi Sun Ahn, Hyun Woo Lee, Seok Yun Kang, Jin-Hyuk Choi, Joon Seong Park. Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation. J Korean Med Sci 2015;30:1416
    https://doi.org/10.3346/jkms.2015.30.10.1416
  4. Yi Chen, Ting Yang, Xiaoyun Zheng, Xiaozhu Yang, Zhihong Zheng, Jing Zheng, Tingbo Liu, Jianda Hu. The outcome and prognostic factors of 248 elderly patients with acute myeloid leukemia treated with standard-dose or low-intensity induction therapy. 2016;95:e4182
    https://doi.org/10.1097/MD.0000000000004182
  5. Mikkael A. Sekeres, Gordon Guyatt, Gregory Abel, Shabbir Alibhai, Jessica K. Altman, Rena Buckstein, Hannah Choe, Pinkal Desai, Harry Erba, Christopher S. Hourigan, Thomas W. LeBlanc, Mark Litzow, Janet MacEachern, Laura C. Michaelis, Sudipto Mukherjee, Kristen O’Dwyer, Ashley Rosko, Richard Stone, Arnav Agarwal, L. E. Colunga-Lozano, Yaping Chang, QiuKui Hao, Romina Brignardello-Petersen. American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. 2020;4:3528
    https://doi.org/10.1182/bloodadvances.2020001920
  6. Hee-Je Kim. How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML. Blood Res 2014;49:75
    https://doi.org/10.5045/br.2014.49.2.75
  7. Kah Poh Loh, Janet A. Tooze, Barbara J. Nicklas, Stephen B. Kritchevsky, Jeff D. Williamson, Leslie R. Ellis, Bayard L. Powell, Timothy S. Pardee, Neha G. Goyal, Heidi D. Klepin. Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia. Journal of Geriatric Oncology 2020;11:410
    https://doi.org/10.1016/j.jgo.2019.03.014
  8. Qingxiao Hong, Xiaoying Chen, Huadan Ye, Xiaodong Wu, Xuejing Wang, Lingyan Kong, Yongming Xia, Shiwei Duan. Chemotherapy-induced hypomethylation of N-myc downstream-regulated gene 4 in the bone marrow of patients with acute myeloid leukemia. 2017;13:3309
    https://doi.org/10.3892/ol.2017.5839
  9. Soo-Mee Bang, Ka-Won Kang, Ik-Chan Song, Cynthia Llamas, Yinghui Duan, Ji-Young Jeong, Je-Hwan Lee. Real-World Treatment Patterns and Clinical Outcomes in Korean Patients With AML Ineligible for First-Line Intensive Chemotherapy: A Subanalysis of the CURRENT Study, a Non-Interventional, Retrospective Chart Review. J Korean Med Sci 2023;38
    https://doi.org/10.3346/jkms.2023.38.e345
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd